Chipscreen(SH:688321) Shang Hai Zheng Quan Bao·2025-10-16 19:28Core Viewpoint - The announcement details a change in equity ownership for Shenzhen Micu Biotechnology Co., Ltd., specifically regarding a reduction in shares held by major shareholder Boao Biological Group Co., Ltd. This change does not involve a takeover bid and will not alter the company's controlling shareholder or actual controller [3][4]. Summary by Sections Equity Change Overview - The equity change is a result of Boao Biological executing a previously disclosed share reduction plan, reducing its holdings from 42,919,572 shares (10.52%) to 40,799,072 shares (10.00%), triggering a change in ownership that touches the 5% integer scale [3][4]. Shareholder Information - Boao Biological and its concerted action party, Tianfu Qingyuan Holdings Co., Ltd., are responsible for the accuracy and completeness of the information provided [3][4]. Shareholding Details - The shares involved in this equity change are all unrestricted circulating shares, and Boao Biological's shares are not subject to any rights restrictions, such as pledges or freezes. Tianfu Qingyuan holds 8,214,410 shares, all of which are frozen [3][12]. Compliance and Regulations - The equity change complies with the relevant laws and regulations, including the Securities Law of the People's Republic of China and the Measures for the Administration of the Acquisition of Listed Companies [3][4]. Future Plans - The shareholders do not rule out the possibility of increasing or further reducing their holdings in Micu Biotechnology within the next 12 months, and they will adhere to disclosure obligations as required by law [11][12].